Phase I Study of 24-Hour Continuous Intravenous Infusion of Recombinant Human Tumor Necrosis Factor
Transient Decrease in IL-2-Responsive Lymphocytes 24 Hours After Initiation of Continuous IL-2 Infusion in Cancer Patients
Phase I Study of Recombinant Gamma-Interferon (rIFN-γ)
Minimal Antigenicity of Intron A in Human Recipients Demonstrated by Three Analytical Methods
Phase I Trial of Recombinant Interleukin-2 and Cyclophosphamide : Augmentation of Cellular Immunity and T-Cell Mitogenic Response with Long-Term Administration of rIL-2
Correlation Between Augmented Resistance to Influenza Virus Infection and Histological Changes in Lung of Mice Treated with Trehalose-6,6'-dimycolate
Modulation of Human Alveolar Macrophage Tumoricidal Activity by C-Reactive Protein
Differences in the Bioactivity of Recombinant Human TNF, LT, and T-Cell-Derived LT-3 on Transformed Cells In Vitro and the Meth A Tumor Growing in BALB/c Mice
Immunoregulatory Effects of Catrix
Oral Use of Human Alpha Interferon in Cats
Second Meeting of the International Association for Vitamin and Nutritional Oncology (IAVNO)